In the present paper, we summarize the involvement of the PI3K/AKT signaling pathway and its downstream effectors in the progression of MASLD/MASH, with a particular focus on the preventive potential of natural monomers and extracts derived from herbal medicines that target this pathway. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.